Resultados de la búsqueda 201-210 of 2973 for VEO-IBD

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct ...

3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

8. Prophylactic Table ID File.indd

   Page 1.

9. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...